Uttar Pradesh, India

Anand Vardhan


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Delhi, IN (1999 - 2000)
  • Ghaziabad, IN (2002)
  • Uttar Pradesh, IN (2011)

Company Filing History:


Years Active: 1999-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Anand Vardhan in Cancer Treatment

Introduction

Anand Vardhan is a notable inventor based in Uttar Pradesh, India. He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 4 patents, Vardhan's work focuses on developing novel compounds that can inhibit tumor growth and improve therapeutic outcomes for cancer patients.

Latest Patents

One of his latest patents involves betulinic acid derivatives. This invention relates to novel betulinic acid derivatives of a specific formula, which are useful for inhibiting tumor cancer cells. The derivatives are designed to interact with various chemical groups, enhancing their efficacy in cancer treatment. Another significant patent is for paclitaxel derivatives aimed at treating various types of cancer, including lung, breast, ovary, cervix, and leukemia. These derivatives are obtained by modifying specific positions of paclitaxel, making them effective in inhibiting cancer growth.

Career Highlights

Anand Vardhan has worked with reputable organizations such as Dabur Research Foundation and Dabur Pharma Limited. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical field. His work has been instrumental in advancing cancer treatment options.

Collaborations

Anand has collaborated with notable colleagues, including Sunder Ramadoss and Manu Jaggi. These collaborations have contributed to the development of his innovative patents and have enhanced the research efforts in cancer treatment.

Conclusion

Anand Vardhan's contributions to cancer treatment through his innovative patents highlight the importance of research and development in the pharmaceutical industry. His work continues to pave the way for new therapeutic options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…